This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.
To INFINITI and Beyond: SGLT2 Inhibitors in Kidney Transplant Patients
A VALIANT effort to combat complement disorders with pegcetacoplan
Top Stories in Nephrology 2025
TenPosts PISCES
Check out PISCES recap: a whale of a tale of fish oil and cardio-protection in ESRD! Thread by NephJC intern Sai Vani
In ESRD is spironolactone an overACHIEVEr?
Las Perspectivas del estudio CRIC: el Resumen Visual
Basado en los datos del estudio CRIC, este análisis profundiza en si esa discordancia (TFGe dif) es solo “ruido”… o una señal clínica que hemos estado ignorando.
Echale un vistazo al resumen visual realizado por el equipo de internos de #NephJC Dr Sai Vani Yellampalli y Akshaya Jayachandran
Insights from the CRIC Study: Visual Abstract
Based on data from the CRIC study, this analysis dives deep into whether this lab mismatch is just noise… or a clinical signal we’ve been missing.
Check out the beautiful visual abstract made by our NephJC interns Sai Vani Yellampalli and Akshaya Jayachandran. Great team work!!!